07:00 , Sep 19, 2005 |  BioCentury  |  Finance

Ebb & Flow

FDA's accidental posting of briefing documents for Celgene's Revlimid a day ahead of schedule gave alert investors an afternoon of arbitrage last Monday. Typically, the agency posts its clinical and statistical reviews of a compound...
07:00 , Jun 9, 2003 |  BioCentury  |  Finance

Ebb & Flow

There's an old Wall Street adage that stock tips given around the shoe shine box or barber poll should be taken as red-hot sell indicators. Perhaps the same should apply to biotech, given that the...
07:00 , Jun 4, 2003 |  BC Extra  |  Financial News

Nanostream raises $22 million

Microfluidics company Nanostream (Pasadena, Calif.) raised $22 million in a series C round co-led by AEA Investors and Lilly BioVentures. Other investors included Techno Venture Management and Flagship Ventures. The funds will be used for...
07:00 , Aug 19, 2002 |  BC Week In Review  |  Company News

Nobex board of directors update

Nobex Corp., Research Triangle Park, N.C.   Business: Drug delivery, Metabolic   Appointed: Michael Berendt, managing director of AEA Investors; Michael Hsu, general partner of EndPoint Merchant Group; and Charles Sanders, former chairman and CEO of...
07:00 , Aug 13, 2002 |  BC Extra  |  Financial News

Nobex raises $35 million

Drug delivery company Nobex raised $35 million in a Series F round led by AEA Investors. Other investors included EndPoint Late Stage Fund I; HealthCap; and a group of Taiwan-based venture capital firms. The company...